Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Summary sheet

Release date
24 March 2023
Status
Reference
Under appraisal | 14/03/2023
20221007
Project name
Promoter - financial intermediary
OLVG AMSTERDAM SUSTAINABLE HEALTHCARE
STICHTING OLVG
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 300 million
EUR 650 million
Location
Sector(s)
  • Health - Human health and social work activities
Description
Objectives

The project supports the strategic investment plan of OLVG, a top-clinical hospital in Amsterdam, to partially renew, renovate and upgrade its two hospital locations. The plan entails the specific restructuring of each of the locations whereby OVLG West facility shall become the clinical centre for acute and high-complex interventions activities, whereas the OLVG East facility will serve as the centre for elective care and oncology.

OLVG has developed a strategic investment plan that will shape its role as top-clinical hospital in Amsterdam going forward. The plan entails a dedicated clinical function for each of the two hospital sites, OLVG West and OLVG East. In order to facilitate the transition to this focussed approach, both locations require a partial renovation and upgrade, whereby location West will also be expanded. The plan shall allow OLVG to further improve the quality of its services at sustainable costs, catalyse specialisation and efficiency, and optimise the hospital facilities for both patients and staff. Furthermore, the project also aims to improve the environmental efficiency of both hospital sites and reduce their carbon footprint.

Environmental aspects
Procurement

Hospitals are not explicitly mentioned in the environmental impact assessment (EIA) Directive 2011/92/EU as amended by 2014/52/EU,though the project is covered by Annex II of the Directive concerning urban development. The Bank's services will verify appraisal during the screening decision of the Competent Authority. It is expected that the project will bear more comprehensive benefits to the community as healthcare is an element of social cohesion and economic development.

The promoter has been assessed by the EIB as being a private company not being subject to EU rules on public procurement or concessions. However, if at the project appraisal, the EIB were to conclude that the Promoter is subject to the EU public procurement legislation then the EIB would duly inform the European Commission Services and would require the Promoter to apply those rules.

Milestone
Under appraisal
Link to source

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

Related publications